Athira Pharma (ATHA) saw its shares tailspin 81% after its lead candidate fosgonimeton failed the Phase II/III LIFT-AD ...

The researchers' ambition was to create a nimble, versatile ChatGPT-like AI platform that can perform a broad range of cancer ...

Understanding age-and sex-related differences in melanoma will provide insights that may help lead to the development of ...

Antibiotic resistance could be overcome if phage therapies were produced more efficiently, for example, through the use of ...

HAYA is developing a pipeline of lncRNA-targeting candidates for the tissue-specific treatment of fibrotic diseases in ...

Researchers identified a unique methylation pattern in brain stem cells that could offer a way to reprogram astrocytes to ...

In looking at data from the 2024 Biopharma Sustainability Review, a shocking 83% of those surveyed are not confident in their ...

Enter MaxCyte, which has been developing and optimizing its Flow Electroporation® technology, allowing cells to move through ...

Radiopharmaceuticals work like radiotherapy but provide localized—rather than external—delivery of a radioisotope.

Sponsored content brought to you by When developing drugs, we rely on animal models to test drugs in an entire system before ...

Symbiotic Capital launches with $600 million-plus in capital, about half of which has been lent to advanced-stage life ...

Investigational mpox mRNA vaccine, developed by Moderna, reduces disease severity in primates compared to available vaccines.